TMS (which stands for Transcranial Magnetic Stimulation) is a non-invasive treatment where a pulsating magnetic field is positioned on the head to externally stimulate specific areas of the brain. This improves the communication between regions of the brain involved in depression and other mental illnesses.
Talking to AM radio (ABC) a spokeswoman from the federal health department indicated that a new mental health committee will be set up in Australia next year with the department welcoming new applications for funding if there’s new evidence for the comparative effectiveness of TMS.
Professor Paul Fitzgerald, neurostimulation expert and fellow of the college of Psychiatry, addresses an immediate problem with this criteria of assessment given that it is difficult to make compare TMS as atherapy, against medications, which are pharmacological.
“We have to try to convince Medicare that the standards by which evidence is being judged pretty much everywhere else in the world, are also reasonable to be applied locally,” says Prof. Fitzgerald in the radio segment.
Neither public nor private health insurance in Australia lists TMS as a subsidised therapy, but public interest in the therapy has increased as its application and efficacy becomes more well-known.
neuroCare which has opened its doorsacross Sydney and Melbourne, is one of the first private practices in Australia to offer TMS in an outpatient setting.
People who do not respond to or who wish to avoid medications to treat Depression, may find an effective alternative inTMS.
A therapy program of TMS can be completed in as little as 7 weeks, with patients attending sessions at least twice per week. Antidepressant effects are often noticed after 10 – 15 sessions, 20 – 30 sessions usually lead to longer lasting results.